Several successful cancer drugs target receptor tyrosine kinases, which phosphorylate proteins to activate them. Now, a group from the Singaporean Agency for Science, Technology and Research has shown that a protein phosphatase may be a useful target for preventing metastasis in triple-negative breast cancer.